- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03136822
DERMALIX Efficacy on Diabetic Foot Ulcers (DERMAN)
August 2, 2018 updated by: Dermis Pharma
Clinical Evaluation of the Wound Dressing Impregnated With Microparticules (DERMALIX) on Diabetic Foot Ulcers
(DERMALIX) (Patent number: PCT/TR2014/000251) is a bioactive wound dressing that was developed by Ege University School of Pharmacy Department of Pharmaceutical Technology.
This dressing has been categorised as Class III medical device.
This clinical study will be conducted in patients with diabetic foot ulcers.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
48
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Izmir, Turkey, 35100
- Ege University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 78 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Type 1 or 2 Patients diagnosed with diabetic foot ulcers
- Class I and II according to Wagner classification
- No infections confirmed with culture test
- No osteomyelitis and gangrene in the foot
- HbA1c values ≤ % 7.5
- Not active smoker
- No planned treatment of hyperbaric oxygen
- Patients who give consent for the study
Exclusion Criteria:
- Patients with diabetic foot ulcer of class 3,4 and 5 according to Wagner classification
- Patients who are pregnant or breast-feeding or female who are in reproductive age applying no preservative method
- Patients who have mental conditions that lead to difficulties in comprehension
- Patients who may have compliance issues
- Patients who have been included to another interventional study with drug or medical device
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Control
Standard dressing
|
Standard dressing is applied for treatment of diabetic foot ulcers
|
Experimental: Treatment
Standard dressing + Wound dressing (DERMALIX)
|
Standard dressing is applied for treatment of diabetic foot ulcers
DERMALIX, a class III Medical Device will be applied in addition to standard dressing
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Recovery of the wound 100%
Time Frame: 1 month
|
The wound will be completely recovered
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Recovery of the wound 80%
Time Frame: 1 month
|
The wound will be recovered by 80%
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sevki Cetinkalp, Prof, Ege University School of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 26, 2017
Primary Completion (Actual)
May 2, 2018
Study Completion (Actual)
August 1, 2018
Study Registration Dates
First Submitted
April 28, 2017
First Submitted That Met QC Criteria
April 28, 2017
First Posted (Actual)
May 2, 2017
Study Record Updates
Last Update Posted (Actual)
August 3, 2018
Last Update Submitted That Met QC Criteria
August 2, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- DERMAN
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetic Foot
-
University of PadovaUnknownDiabetic Foot | Diabetic Foot Ulcer | Diabetic Foot Infection | Diabetic Foot Ulcer Neuropathic | Deformities FootItaly
-
Johns Hopkins UniversityWithdrawnDiabetic Foot | Diabetic Foot Ulcer | Diabetic Foot Infection | Diabetic Foot Ulcer Mixed | Vascular Ulcer (Arterial or Venous Including Diabetic Ulcers Not Located on the Foot)
-
Integra LifeSciences CorporationMayo Clinic; Temple University; Samuel Merritt University; New York College of... and other collaboratorsCompletedFoot Ulcers, DiabeticUnited States
-
Community Pharmacology Services LtdKeneric HealthcareNot yet recruitingDiabetic Foot Ulcer | Diabetic Foot Ulcer Neuropathic | Diabetic Foot Ulcer Ischemic
-
Exciton Technologies Inc.CompletedDiabetic Foot Ulcer | Diabetic Foot Infection | Non-healing Diabetic Foot UlcerCanada
-
Corporacion Parc TauliCompletedDiabetic Foot Ulcer | Diabetic Foot Ulcer NeuropathicPakistan
-
University of the PunjabHigher Education Commission (Pakistan); Centre of Excellence in Molecular Biology... and other collaboratorsRecruitingDiabetes Mellitus | Diabetic Foot | Foot Ulcer | Diabetes Complications | Diabetic Foot Ulcer | Diabetic Foot Infection | Diabetic Foot Ulcer Neuropathic | Foot Ulcer Due to Type 1 Diabetes Mellitus | Foot Ulcer Due to Type 2 Diabetes Mellitus | Chronic Diabetic Ulcer of Left Foot | Chronic Diabetic Foot...Pakistan
-
University of MinnesotaRecruitingDiabetes Mellitus | Foot Ulcer | Ulcer | Diabetic Foot Ulcer | Foot Ulcer, Diabetic | Ulcer Foot | Ulcer, Leg | Ankle UlcerUnited States
-
HealthpointCompletedDiabetic Foot Ulcers | Diabetic Foot WoundsUnited States, Canada
-
HealthpointCompleted
Clinical Trials on Standard Dressing
-
Community Pharmacology Services LtdKeneric HealthcareNot yet recruitingDiabetic Foot Ulcer | Diabetic Foot Ulcer Neuropathic | Diabetic Foot Ulcer Ischemic
-
United States Army Institute of Surgical ResearchCompleted
-
Stanford UniversityWithdrawn
-
University Hospital of LimerickCompleted
-
Indiana UniversityCompletedHypertrophic Skin Condition of Anterior AbdomenUnited States
-
Medical University of South Carolina3MRecruitingSarcoma | Cancer | Infectious DiseaseUnited States
-
3MTerminated
-
Tufts Medical CenterTerminatedObesity | Surgical Site Infections | Complications; Cesarean Section | Wound ComplicationsUnited States
-
Halyard HealthTerminatedBreast Cancer | Reconstructive Breast SurgeryUnited States
-
Johns Hopkins UniversityKinetic Concepts, Inc.TerminatedObesity | Postoperative Complications | Wound Infection, SurgicalUnited States